
Merck has a reported market valuation of approximately $204.88 billion with 2.53 billion outstanding shares. The company’s leadership has opted to commit its resources towards developing coronavirus therapy drugs.
Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.
Merck & Co., Inc., d.b.a. Merck Sharp & Dohme (MSD) outside the United States and Canada, is an American multinational pharmaceutical company and one of the largest pharmaceutical companies in the world. Merck is incorporated in New Jersey.
The company was established in 1891 as the United States subsidiary of the German company Merck, which was founded in 1668 by the Merck family. Merck & Co. was expropriated by the US government during World War I and subsequently established as an independent American company in 1917. While it operates as Merck & Co. in the United States and Canada, the original Merck based in Darmstadt holds the rights to the Merck name everywhere else. Merck & Co. is the world’s seventh largest pharmaceutical company by market capitalization and revenue. Its headquarters is located in Kenilworth, New Jersey. The company ranked No. 78 in the 2018 Fortune 500 list of the largest United States corporations by total revenue.
Merck & Co. publishes The Merck Manuals, a series of medical reference books for physicians, nurses, technicians, and veterinarians. These include the Merck Manual of Diagnosis and Therapy, the world’s best-selling medical reference. The Merck Index, a compendium of chemical compounds, was formerly published by Merck & Co. before being acquired by the Royal Society of Chemistry in 2012.
Merck has a reported market valuation of approximately $204.88 billion with 2.53 billion outstanding shares. The company’s leadership has opted to commit its resources towards developing coronavirus therapy drugs.
The deal with OncoImmune will see Merck take up the ownership of CD24Fc with additional payment made to OncoImmune based on future favorable regulatory approvals associated with the drug.
Moreover, through Berkshire Hathaway Warren Buffett has made a number of other investments in several industries this year besides the pharmaceutical stocks.